Podcast: Meet our researchers
Webinar
Join our webinar The ethics, safety and justification for evaluating hydroxychloroquine and chloroquine to prevent COVID-19 (download pdf), on Tuesday, 26 January 2021 at 10:00 New York | 12:00 São Paolo | 16:00 Geneva | 20:30 Delhi | 22:00 Bangkok. Register
copcov study
Needed: Healthcare staff for the #COPCOV drug trial to prevent COVID-19.
There is increasing evidence that hydroxychloroquine has some preventive COVID-19 benefit. COPCOV is the world’s largest trial trying to determine: Can hydroxychloroquine help prevent COVID-19 in healthcare workers? To enrol in the UK, visit the COPCOV registration site.
What's new
Latest publications
-
Probabilistic transmission models incorporating sequencing data for healthcare-associated Clostridioides difficile outperform heuristic rules and identify strain-specific differences in transmission
Journal article
Eyre DW. et al, (2021), PLOS Computational Biology, 17, e1008417 - e1008417
-
Epidemiological Characteristics, Ventilator Management, and Clinical Outcome in Patients Receiving Invasive Ventilation in Intensive Care Units from 10 Asian Middle-Income Countries (PRoVENT-iMiC): An International, Multicenter, Prospective Study.
Journal article
Pisani L. et al, (2021), The American journal of tropical medicine and hygiene
-
Optimal design for phase 2 studies of SARS-CoV-2 antiviral drugs
Journal article
Watson JA. et al, (2021)